Connecticut spent almost 1 percent of total state government expenditures on costs associated with the opioid crisis in fiscal year 2015.

That’s according to a new analysis by the Federal Reserve Bank of Boston that looked at costs associated with the opioid crisis in New England. At 1 percent, Connecticut ranks toward the higher end of New England states when it comes to opioid expenditures.

The state spent more than Vermont and a fraction more than Massachusetts, but less than Rhode Island and Maine, which spent 1.14 percent of total expenditures on costs associated with the crisis. The U.S. government spent .74 percent of its total expenditures on the opioid crisis, putting it below every New England state.

The Fed broke out the costs each state spent into several categories: criminal justice, medical treatment and medical complications. Connecticut spent $89.80 per capita; the highest category of spending was for medical treatment at about $177 million.

The opioid epidemic’s impact on state revenues is significant and could affect regional fiscal health, the Fed said. For example, individuals incarcerated for drug crimes or in residential treatment programs are not earning wages. Evidence also suggests that non-institutionalized individuals abusing opioids are more likely out of work than employed, likewise resulting in lost revenue.

The opioid crisis has hit Connecticut hard in recent years, putting a significant burden on local police and fire departments, as well as other municipal departments. According to state data, heroin-related deaths in 2017 declined to 474 from 541 a year before, but fentanyl deaths shot up to 677, almost 200 deaths higher than in 2016.

Overall, accidental intoxication deaths hit 1,038 in 2017, up 121 deaths from 2016.